MDER (Medera) EV-to-EBIT: 0.00 (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Medera EV-to-EBIT?

Medera MDER EV-to-EBIT is 0.00 as of Sep. 22, 2026.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medera's Enterprise Value is $0.00 Mil. Medera's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $-10.06 Mil. Therefore, Medera's EV-to-EBIT for today is 0.00.

The historical rank and industry rank for Medera's EV-to-EBIT or its related term are showing as below:

MDER's EV-to-EBIT is not ranked *
in the Biotechnology industry.
Industry Median: 14.08
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Medera's Enterprise Value for the quarter that ended in Jun. 2024 was $0.00 Mil. Medera's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $-10.06 Mil. Medera's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was %.

Medera  (NAS:MDER) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Medera's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2024 ) =EBIT / Enterprise Value (Q: Jun. 2024 )
=-10.058/0
= %

Medera's Enterprise Value for the quarter that ended in Jun. 2024 was $0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medera's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $-10.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medera EV-to-EBIT Related Terms

Medera EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Medera's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medera EV-to-EBIT Chart

Medera Annual Data
Trend Dec22 Dec23
EV-to-EBIT
0.00 0.00

Medera Semi-Annual Data
Dec22 Jun23 Dec23 Jun24
EV-to-EBIT 0.00 0.00 0.00 0.00

MDER vs : EV-to-EBIT Comparison

For the Biotechnology subindustry, Medera's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medera EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medera's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medera's EV-to-EBIT falls into.


Medera EV-to-EBIT Calculation

Medera's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/-10.058
=0.00

Medera's current Enterprise Value is $0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medera's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $-10.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of 0.00 mean?
Medera (MDER) has a EV-to-EBIT of 0.00 as of Sep. 22, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Medera and its competitors.
Is Medera's EV-to-EBIT too high?
Medera's current EV-to-EBIT is 0.00.
How does Medera's EV-to-EBIT compare to ?
Medera's EV-to-EBIT of 0.00 can be compared against companies in the Biotechnology industry. The industry median EV-to-EBIT is 14.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Biotechnology company?
The median EV-to-EBIT among Biotechnology companies is 14.08, based on 381 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Medera and its competitors. For the Biotechnology industry, the median EV-to-EBIT is 14.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medera's current EV-to-EBIT is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medera stock overvalued right now?
Medera (MDER) has a current EV-to-EBIT of 0.00. The current EV-to-EBIT is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Medera (MDER), the current EV-to-EBIT is 0.00 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medera Business Description

Comparable Companies
Address 6 Tide Street, 2nd Floor, Boston, MA, USA, 02210
Medera Inc is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates through two arms, namely: (1) pre-clinical disease modeling and drug discovery under Medera's Novoheart brand, which includes its bioengineered human mini-heart technology platform and related state-of-the-art technologies for preclinical screening; and (2) clinical development of novel therapies under Medera's Sardocor brand, which aspires to create the shortest regulatory path to clinic for advancing next-generation gene therapies (by leveraging the above Novoheart platform), in particular, for cardiovascular diseases.